Hypothesis: Bimetallic nanoparticles have continued to attract interest as drug delivery systems in cancer therapy even though their nature of interaction with small molecules is limited. Currently, many delivery systems based on monometallic nanoparticles are being fabricated for loading of drugs, thus prompting the need to explore and get more understanding of dendritic bimetallic nanostructure-drug interaction.
Experiments: The bimetallic gold-core palladium-dendritic shell nanoparticles (Au@PdNDs) were synthesized by hot injection method and stabilized with methoxy polyethylene glycol thiol (mPEG-SH). An anti-cancer drug, doxorubicin (DOX) was conjugated to the bimetallic nanodendrites leading to the formation of DOX/Au@PdNDs.PEG complex. We used TEM, FTIR, and zeta-potential to study the drug-nanodendrites interaction. The effect of DOX binding and release capacity with regards to pH, adsorption kinetics, solvent polarity, isotherms and temperature on Au@PdNDs.PEG were investigated.
Findings: The results showed a spontaneous heterogeneous binding of DOX on the Au@PdNDs.PEG surfaces and time-dependent loading capacity of ~90% maximum adsorption within 24 h. Moreover, the experimental results showed that the adsorption isotherm data fitted well with the Freundlich model and a pseudo-second order adsorption kinetics. The desorption of DOX was triggered under simulated tumor microenvironmental conditions and should open new opportunities for potential multi stimuli-responsive drug delivery applications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.msec.2020.110696 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast Cancer.
Clin Breast Cancer
December 2024
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK. Electronic address:
Introduction: Adjuvant abemaciclib was recently approved in high-risk early breast cancer, leading to an increase in oncology resource utilisation. We thus developed a regional, remote monitoring clinical service. The set-up, delivery processes and outcomes from the first 6 months' consecutive patients are presented.
View Article and Find Full Text PDFIdentifying people with post-COVID condition using linked, population-based administrative health data from Manitoba, Canada: prevalence and predictors in a cohort of COVID-positive individuals.
BMJ Open
January 2025
Department of Statistics, University of Manitoba, Winnipeg, Manitoba, Canada.
Objective: Many individuals exposed to SARS-CoV-2 experience long-term symptoms as part of a syndrome called post-COVID condition (PCC). Research on PCC is still emerging but is urgently needed to support diagnosis, clinical treatment guidelines and health system resource allocation. In this study, we developed a method to identify PCC cases using administrative health data and report PCC prevalence and predictive factors in Manitoba, Canada.
View Article and Find Full Text PDFIron-Based Nanomaterials for Modulating Tumor Microenvironment.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
January 2025
Laboratory of Advanced Theranostic Materials and Technology, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, China.
Iron-based nanomaterials (IBNMs) have been widely applied in biomedicine applications including magnetic resonance imaging, targeted drug delivery, tumor therapy, and so forth, due to their unique magnetism, excellent biocompatibility, and diverse modalities. Further research on its enormous biomedical potential is still ongoing, and its new features are constantly being tapped and demonstrated. Among them, various types of IBNMs have demonstrated significant cancer therapy capabilities by regulating the tumor microenvironment (TME).
View Article and Find Full Text PDFPre-assembled nanospheres in mucoadhesive microneedle patch for sustained release of triamcinolone in the treatment of oral submucous fibrosis.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
August 2024
Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University; Hunan Engineering Research Center for Oral Digital Intelligence and Personalized Medicine; Hunan 3D Printing Engineering Research Center of Oral Care; WANG Songling Academician Workstation for Oral-maxilofacial and Regenerative Medicine, Central South University, Changsha 410078.
Objectives: Drug-loaded mucoadhesive silk fibroin (SF) microneedle patch can overcome the limitations of low bioavailability and significant pain associated with traditional treatment methods, such as topical application or injection of triamcinolone for oral submucous fibrosis (OSF). However, these systems release the drug too quickly, failing to meet the clinical requirements. This study aims to construct a mucoadhesive SF microneedle patch pre-assembled with silk fibroin nanospheres (SFN) and explore its ability to sustain the release of triamcinolone in the treatment of OSF.
View Article and Find Full Text PDFEmerging nanotechnology-driven drug delivery solutions for malaria: Addressing drug resistance and improving therapeutic success.
Int J Pharm
January 2025
Centre for Transgenic Plant Development, Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India. Electronic address:
Malaria remains the fifth deadliest parasitic infection worldwide, despite significant advancements in technology. A major challenge in combating this disease lies in the growing resistance of malaria parasites to antimalarial drugs and insect vectors to insecticides. The emerging inefficacy of artemisinin-based combination therapies (ACTs) further exacerbates the issue.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!